company background image
NEIMETH

Neimeth International Pharmaceuticals NGSE:NEIMETH Stock Report

Last Price

₦1.38

Market Cap

₦2.6b

7D

0%

1Y

-21.1%

Updated

28 Nov, 2022

Data

Company Financials
NEIMETH fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends1/6

NEIMETH Stock Overview

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical, animal health, and general healthcare products in Nigeria and Ghana.

Neimeth International Pharmaceuticals Plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Neimeth International Pharmaceuticals
Historical stock prices
Current Share Price₦1.38
52 Week High₦1.98
52 Week Low₦1.26
Beta0.84
1 Month Change-8.00%
3 Month Change-12.10%
1 Year Change-21.14%
3 Year Change89.04%
5 Year Change153.00%
Change since IPO-32.58%

Recent News & Updates

Recent updates

Shareholder Returns

NEIMETHNG PharmaceuticalsNG Market
7D0%4.6%5.4%
1Y-21.1%15.8%-1.2%

Return vs Industry: NEIMETH underperformed the NG Pharmaceuticals industry which returned 15.8% over the past year.

Return vs Market: NEIMETH underperformed the NG Market which returned -1.2% over the past year.

Price Volatility

Is NEIMETH's price volatile compared to industry and market?
NEIMETH volatility
NEIMETH Average Weekly Movement5.3%
Pharmaceuticals Industry Average Movement4.3%
Market Average Movement5.5%
10% most volatile stocks in NG Market6.9%
10% least volatile stocks in NG Market2.8%

Stable Share Price: NEIMETH is not significantly more volatile than the rest of NG stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: NEIMETH's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1957202Pharm. Matthew Azojihttps://www.neimethplc.com.ng

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical, animal health, and general healthcare products in Nigeria and Ghana. It operates through Pharmaceuticals and Animal Health segments. The company provides health care, ethical, and veterinary products.

Neimeth International Pharmaceuticals Plc Fundamentals Summary

How do Neimeth International Pharmaceuticals's earnings and revenue compare to its market cap?
NEIMETH fundamental statistics
Market Cap₦2.62b
Earnings (TTM)-₦109.66m
Revenue (TTM)₦2.70b

1.0x

P/S Ratio

-23.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
NEIMETH income statement (TTM)
Revenue₦2.70b
Cost of Revenue₦1.63b
Gross Profit₦1.07b
Other Expenses₦1.18b
Earnings-₦109.66m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.058
Gross Margin39.74%
Net Profit Margin-4.06%
Debt/Equity Ratio304.5%

How did NEIMETH perform over the long term?

See historical performance and comparison

Dividends

5.1%

Current Dividend Yield

-121%

Payout Ratio